00:00
02:53
Dr. Nathan Pennell, Cleveland Clinic, describes treatment of NSCLC patients with HER2 mutations using agents such as Gilotrif or Herceptin.
Dr. Nathan Pennell, Cleveland Clinic, describes treatment of NSCLC patients with HER2 mutations using agents such as Gilotrif or Herceptin. read more read less

8 years ago #afatinib, #cancer, #cancergrace, #chemotherapy, #expression, #grace, #gracecast, #her2, #iv, #lung, #match, #mutation, #nate, #nathan, #nsclc, #pennell, #stage, #targeted, #therapy, #trial